Characterization of CD56bright NK cells in Daclizumab HYP-treated RRMS patients

被引：0

作者：

Huss, David J. ^{[1
]}

Fragoso, Maria F. ^{[1
]}

Cullen, Patrick ^{[2
]}

Allaire, Norm ^{[2
]}

Fontenot, Jason D. ^{[1
]}

机构：

[1] Biogen Idec Inc, Immunol Res, Cambridge, MA USA

[2] Biogen Idec Inc, Genet & Genom, Cambridge, MA USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期

关键词：

D O I：

10.1016/j.jneuroim.2014.08.230

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

213

引用

页码：86 / 86

页数：1

共 50 条

[41] Enhanced migration of CD56bright NK cells across hCMEC/D3 in interferon-beta-1a treated multiple sclerosis patients
Harrer, A.
Wanek, J.
Oppermann, K.
Wimmer, M.
Zauner, R.
Couraud, P. -O.
Romero, I. A.
Weksler, B.
Afazel, S.
Haschke-Becher, E.
Wipfler, P.
Pilz, G.
Trinka, E.
Sellner, J.
Kraus, J.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 321 - 322
[42] CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation
Dalbeth, N
Gundle, R
Davies, RJO
Lee, YCG
McMichael, AJ
Callan, MFC
JOURNAL OF IMMUNOLOGY, 2004, 173 (10): : 6418 - 6426
[43] Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56bright NK cells
Mele, Dalila
Mantovani, Stefania
Oliviero, Barbara
Grossi, Giulia
Lombardi, Andrea
Mondelli, Mario U.
Varchetta, Stefania
JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1148 - 1156
[44] The Increased Ratio of Blood CD56bright NK to CD56dim NK Is a Distinguishing Feature of Primary Sjogren's Syndrome
Ming, Bingxia
Wu, Tong
Cai, Shaozhe
Hu, Peng
Tang, Jungen
Zheng, Fang
Ye, Cong
Dong, Lingli
JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
[45] Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56bright NK Cells in Patients with Chronic Gvhd
Kubo, Tomohiro
Romee, Rizwan
Koreth, John
Belizaire, Roger
Kamihara, Yusuke
Liu, Hongye
Asano, Takeru
Whangbo, Jennifer
Hirakawa, Masahiro
Nikiforow, Sarah
Gooptu, Mahasweta
Ho, Vincent T.
Cutler, Corey S.
Alyea, Edwin P., III
Antin, Joseph H.
Soiffer, Robert J.
Ritz, Jerome
BLOOD, 2018, 132
[46] CD56bright CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy
Tao, Yu
Li, Yan-Hong
Piao, Hai-Lan
Zhou, Wen-Jie
Zhang, Di
Fu, Qiang
Wang, Song-Cun
Li, Da-Jin
Du, Mei-Rong
CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (01) : 77 - 86
[47] CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
Wagner, Julia A.
Rosario, Maximillian
Romee, Rizwan
Berrien-Elliott, Melissa M.
Schneider, Stephanie E.
Leong, Jeffrey W.
Sullivan, Ryan P.
Jewell, Brea A.
Becker-Hapak, Michelle
Schappe, Timothy
Abdel-Latif, Sara
Ireland, Aaron R.
Jaishankar, Devika
King, Justin A.
Vij, Ravi
Clement, Dennis
Goodridge, Jodie
Malmberg, Karl-Johan
Wong, Hing C.
Fehniger, Todd A.
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (11): : 4042 - 4058
[48] Immunophenotypic and proteomic characterization of cord blood(CB)CD56BRIGHT and CD56DIM NK cells:: Potential role of CBCD56 dim mediating GVL effect
Shereck, E.
Satwani, P.
van de Ven, C.
Ayello, J.
Crockett, D.
Lim, M.
Wapner, R. J.
Day, N.
Jiang, H.
Cairo, M. S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 128 - 129
[49] The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56bright NK cells
Ziegler, Annerose E.
Fittje, Pia
Mueller, Luisa M.
Ahrenstorf, Annika E.
Hagemann, Kerri
Hagen, Sven H.
Hess, Leonard U.
Niehrs, Annika
Poch, Tobias
Ravichandran, Gevitha
Loebl, Sebastian M.
Padoan, Benedetta
Brias, Sebastien
Hennesen, Jana
Richard, Myrtille
Richert, Laura
Peine, Sven
Oldhafer, Karl J.
Fischer, Lutz
Schramm, Christoph
Martrus, Gloria
Bunders, Madeleine J.
Altfeld, Marcus
Lunemann, Sebastian
FRONTIERS IN IMMUNOLOGY, 2023, 14
[50] Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56Bright NK Cells in Patients With Chronic GvHD
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 11 - 12

← 1 2 3 4 5 →